Clinical Evidence of Kidney Protection Exerted by SGLT2 Inhibitors

More on Chronic kidney disease

• The American Journal of Cardiology·8 Oct 2026

  Drug class linked to fewer deaths or complications in kidney disease

  

• Clinical Journal of the American Society of Nephrology·4 Oct 2026

  SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes

• Clinical Pharmacology and Therapeutics·4 Oct 2026

  SGLT2 inhibitors raise genital but not urinary infection risk

• Frontiers in Endocrinology·4 Oct 2026

  Underweight is linked to higher kidney disease risk in diabetes